Design Therapeutics (DSGN) Enterprise Value
Price: $3.79
Market Cap: $215.13M
Avg Volume: 161.77K
Market Cap: $215.13M
Avg Volume: 161.77K
Country: US
Industry: Biotechnology
Sector: Healthcare
Industry: Biotechnology
Sector: Healthcare
Enterprise Value Summary (Quarterly)
According to Design Therapeutics's latest quarterly financial reports:
- The enterprise value (EV) is 328.91M, which includes the market capitalization, debt, and subtracts cash and cash equivalents. EV provides a more comprehensive measure of a company's total value.
- The market capitalization is 349.14M, which is calculated by multiplying the current share price by the total number of outstanding shares.
- The stock price is $6.17, with 56.59M shares outstanding.
- The company has 22.56M in cash and cash equivalents and 2.33M in total debt.
Enterprise Value (EV) Formula:
EV = Market Cap + Total Debt - Cash and Cash Equivalents
Enterprise value is often used instead of market cap because it provides a more accurate valuation of a company by including debt and subtracting cash, giving a fuller picture of the company's total value.
Enterprise Value
$328.91M
Market Cap
$349.14M
Total Debt
$2.33M
Cash and Equivalents
$22.56M
Historical Enterprise Value
Design Therapeutics Historical Enterprise Values
The table below shows various enterprise value metrics for each quarter, with the latest data available for 2024-12-31.
| Date | Enterprise Value | EV Change (%) | Stock Price | Number of Shares | Market Cap | Cash & Equivalents | Total Debt |
|---|---|---|---|---|---|---|---|
| December 31, 2024 | $328.91M | 18.82% | $6.17 | 56.59M | $349.14M | $22.56M | $2.33M |
| September 30, 2024 | $276.81M | 96.59% | $5.38 | 56.62M | $304.62M | $30.33M | $2.52M |
| June 30, 2024 | $140.81M | -29.79% | $3.25 | 56.56M | $183.81M | $45.70M | $2.70M |
| March 31, 2024 | $200.56M | 53.51% | $4.02 | 56.49M | $227.08M | $29.40M | $2.88M |
| December 31, 2023 | $130.65M | 21.64% | $2.65 | 56.15M | $148.80M | $21.20M | $3.05M |
| September 30, 2023 | $107.41M | -67.32% | $2.36 | 55.99M | $132.13M | $27.94M | $3.22M |
| June 30, 2023 | $328.66M | 10.79% | $6.3 | 55.95M | $352.48M | $27.20M | $3.38M |
| March 31, 2023 | $296.66M | -46.10% | $5.77 | 55.91M | $322.59M | $28.81M | $2.88M |
| December 31, 2022 | $550.36M | -38.44% | $10.26 | 55.86M | $573.17M | $26.50M | $3.69M |
| September 30, 2022 | $894.00M | 34.70% | $16.72 | 55.78M | $932.68M | $42.52M | $3.84M |
| June 30, 2022 | $663.72M | 8.34% | $14 | 55.67M | $779.39M | $119.65M | $3.98M |
| March 31, 2022 | $612.65M | -31.19% | $16.15 | 55.51M | $896.44M | $287.31M | $3.52M |
| December 31, 2021 | $890.37M | 95.12% | $21.41 | 55.36M | $1.19B | $298.57M | $3.63M |
| September 30, 2021 | $456.31M | -37.04% | $14.69 | 55.16M | $810.23M | $357.66M | $3.75M |
| June 30, 2021 | $724.73M | 473.14% | $19.89 | 55.08M | $1.10B | $370.84M | $- |
| March 31, 2021 | $126.45M | -88.77% | $29.9 | 17.63M | $527.14M | $400.69M | $- |
| December 31, 2020 | $1.13B | -0.21% | $41.49 | 27.19M | $1.13B | $2.38M | $- |
| September 30, 2020 | $1.13B | 0.00% | $41.49 | 27.19M | $1.13B | $- | $- |
| June 30, 2020 | $1.13B | -0.01% | $41.49 | 27.19M | $1.13B | $- | $- |
| March 31, 2020 | $1.13B | - | $41.49 | 27.19M | $1.13B | $-77.00K | $- |
Related Metrics
Explore detailed financial metrics and analysis for DSGN.